Glycopyrronium bromide is a medication of the muscarinic anticholinergic group. It does not cross the blood–brain barrier and consequently has no to few central effects. A synthetic quaternary amine, it is available in oral and intravenous (i.v.) forms. It was developed by Sosei and licensed to Novartis in 2005. The cation, which is the active moiety, is also known as Glycopyrronium.

CAS：596-51-0
中文别名：
英文别名：Pyrrolidinium, 3-[(cyclopentylhydroxyphenylacetyl)oxy]-1,1-dimethyl-, bromide;Glycopyrrolate;
分子式：C19H28BrNO3
分子量：398.335
精确质量：397.125
Psa：46.53
Logp：-0.5809

EINECS号：209-887-0

外观与性状：白色粉末
熔点：193 - 194.5ºC
储存条件：Store cool, dry and dark.

海关编码：2933990090

用途
抗酸及抗溃疡。